The decline in Corvus Pharmaceuticals' share price is a direct reaction to the company's Q1 financial results. Typically, financial results can have a significant impact on stock prices, especially if they fall short of market expectations. The negative reaction suggests that the results may have been below investor expectations, leading to a decrease in stock value in the short term.